rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Pat Beyer

Director

Company insider

Files Form 4 as: Director, Bioventus; President & CEO, Conmed; Director, Misonix.

In numbers

Trades disclosed
84
Buys
2
Sells
2
Bought
$472K
Sold
$6.3M
Companies
3
Companies where not an officer
2
First trade
27 Feb 2015
Last trade
3 Jun 2026
Last filed
4 Jun 2026

Companies traded

Where they are an officer
CNMD ConmedOfficer · Medical Devices · last 1 Apr 20262 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
BVS BioventusDirector · Medical Devices · last 3 Jun 20260 buys · 0 sells
MisonixDirector · last 29 Oct 20210 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
3 Jun 2026filed 4 Jun 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code A—25,146 at $0.00filing
3 Jun 2026filed 4 Jun 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code A—25,146 at $0.00filing
2 Jun 2026filed 4 Jun 2026BVS BioventusMedical DevicesSEC FORM 4 Code M—32,282 at $0.00filing
2 Jun 2026filed 4 Jun 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code M—32,282 at $0.00filing
2 Jun 2026filed 4 Jun 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code M—32,282 at $0.00filing
2 Jun 2026filed 4 Jun 2026BVS BioventusMedical DevicesSEC FORM 4 Code M—32,282 at $0.00filing
1 Apr 2026filed 2 Apr 2026CNMD Conmedoption or derivative · Medical DevicesSEC FORM 4 Code A—28,145 at $0.00filing
1 Apr 2026filed 2 Apr 2026CNMD Conmedoption or derivative · Medical DevicesSEC FORM 4 Code A—28,145 at $0.00filing
2 Mar 2026filed 4 Mar 2026CNMD Conmedoption or derivative · Medical DevicesSEC FORM 4 Code A—28,800 at $0.00filing
2 Mar 2026filed 4 Mar 2026CNMD Conmedoption or derivative · Medical DevicesSEC FORM 4 Code A—68,258 at $0.00filing
2 Mar 2026filed 4 Mar 2026CNMD Conmedoption or derivative · Medical DevicesSEC FORM 4 Code A—28,800 at $0.00filing
2 Mar 2026filed 4 Mar 2026CNMD Conmedoption or derivative · Medical DevicesSEC FORM 4 Code A—68,258 at $0.00filing
3 Jun 2025filed 4 Jun 2025BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code A—32,282 at $0.00filing
2 Jun 2025filed 4 Jun 2025BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code M—26,493 at $0.00filing
2 Jun 2025filed 4 Jun 2025BVS BioventusMedical DevicesSEC FORM 4 Code M—26,493 at $0.00filing
2 Jan 2025filed 6 Jan 2025CNMD Conmedoption or derivative · Medical DevicesSEC FORM 4 Code A—86,355 at $0.00filing
16 Jun 2024filed 18 Jun 2024BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code M—965 at $0.00filing
16 Jun 2024filed 18 Jun 2024BVS BioventusMedical DevicesSEC FORM 4 Code M—965 at $0.00filing
11 Jun 2024filed 13 Jun 2024BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code A—26,493 at $0.00filing
7 Jun 2024filed 11 Jun 2024BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code M—30,400 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Kim KeldermanDirector · Director at Conmed, filing Form 4 there in the last year
John E. GallagherExecutive Vice President & CFO · Executive Vice President & CFO at Conmed, filing Form 4 there in the last year
Jeffrey B. MirvissDirector · Director at Conmed, filing Form 4 there in the last year
Celine Christine MartinDirector · Director at Conmed, filing Form 4 there in the last year
Barbara J. SchwarzentraubDirector · Director at Conmed, filing Form 4 there in the last year